Sun Pharma Can't Quell Patent Feud Over Epilepsy Drug
A New Jersey federal judge on Monday refused to dismiss claims against Sun Pharmaceuticals Ltd. in a patent suit over Sun's generic version of Cephalon Inc.'s anti-epilepsy drug, holding that Cephalon's...To view the full article, register now.
Already a subscriber? Click here to view full article